Richard C. Taylor, M.D.

  1. Internist
  2. Oncologist
  3. Palliative Care Specialist
  1. Gray N, Christensen KJ, Rhee LS, Strand J, Allen G, Ramirez C, Patel C, Taylor R, Greer JA, Temel JS, El-Jawahri A, Rinaldi S, Kamdar M, Park ER, Horick NK, Pintro K, Rabideau DJ, Schwamm L, Feliciano J, Chua I, Leventakos K, Fischer SM, Campbell TC, Rabow MW, Zachariah F, Hanson LC, Martin SF, Silveira M, Shoemaker L, Bakitas M, Bauman J, Spoozak L, Grey C, Blackhall L, Curseen K, O'Mahony S, Smith MM, Rhodes R, Cullinan A, Jackson V, REACH PC Investigators. Telehealth vs In-Person Early Palliative Care for Patients With Advanced Lung Cancer: A Multisite Randomized Clinical Trial. JAMA. 2024 Sep 11 Epub 2024 Sept 11
    View PubMed
  2. Melody M, Bruning C, Mack R, Parrott K, Taylor R, Kaur J, Ayala E, Kharfan-Dabaja M, Murthy H, Kilpatrick M, Robinson M. CT-019 Patient Perceptions of Palliative Care in the Process of Allogenic Stem Cell Transplantation. Clin Lymphoma Myeloma Leuk. 2022 Oct; 22 Suppl 2:S431
    View PubMed
  3. Lesser GJ, Irby MB, Taylor RC, Snavely A, Case D, Wang A, Dietrich A, Duncan S. Lactoferrin supplementation for taste and smell abnormalities among patients receiving cancer chemotherapy. Support Care Cancer. 2022 Mar; 30 (3):2017-2025 Epub 2021 Oct 13
    View PubMed
  4. Porosnicu M, O'Brien Cox A, Waltonen JD, Bunch PM, D'Agostino R, Lycan TW, Taylor R, Williams DW 3rd, Chen X, Shukla K, Kouri BE, Walker T, Kucera G, Patwa HS, Sullivan CA, Browne JD, Furdui CM. Early [18]FDG PET/CT scan predicts tumor response in head and neck squamous cell cancer patients treated with erlotinib adjusted per smoking status. Front Oncol. 2022; 12:939118 Epub 2022 Aug 30
    View PubMed
  5. Faig J, Haughton M, Taylor R, D'Agostino R, Rodriguez K, Murea M, Porosnicu M. Retrospective Analysis of Cisplatin Nephrotoxicty in Paient with Head and Neck Cancer Receiving Outpatient Treatment with Concurrent High-Dose Cisplatin and Radiotherapy. American Journal of Clinic Oncology. 2016.